Legal Representation
Attorney
B. Brett Heavner
USPTO Deadlines
Next Deadline
150 days remaining
Statement of Use Due - Extension 2 Granted
Due Date
December 04, 2025
Extension Available
Until June 04, 2025
Application History
32 events| Date | Code | Type | Description |
|---|---|---|---|
| May 15, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| May 15, 2025 | EX2G | S | SOU EXTENSION 2 GRANTED |
| May 14, 2025 | EXT2 | S | SOU EXTENSION 2 FILED |
| May 14, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Oct 9, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Oct 9, 2024 | EXT1 | S | SOU EXTENSION 1 FILED |
| Oct 9, 2024 | EX1G | S | SOU EXTENSION 1 GRANTED |
| Oct 9, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Jun 4, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Apr 2, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Apr 2, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Mar 13, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Feb 27, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Feb 27, 2024 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
| Feb 27, 2024 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Feb 27, 2024 | GNEA | O | EXAMINERS AMENDMENT E-MAILED |
| Feb 27, 2024 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
| Jan 18, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Jan 18, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Jan 18, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Nov 20, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Nov 20, 2023 | GNRT | O | NON-FINAL ACTION E-MAILED |
| Nov 20, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Oct 24, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Oct 23, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Oct 23, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Sep 12, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Sep 12, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED |
| Sep 12, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Sep 12, 2023 | DOCK | D | ASSIGNED TO EXAMINER |
| Jan 27, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Jan 7, 2023 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 016
Printed materials, namely, newsletters in the field of cardiovascular diseases and conditions, speaker communications in the nature of printed articles in the field of cardiovascular diseases and conditions, magazines in the field of cardiovascular diseases and conditions, catalogues in the field of cardiovascular diseases and conditions, posters, informational flyers featuring cardiovascular diseases and conditions, brochures in the field of cardiovascular diseases and conditions, pamphlets in the field of cardiovascular diseases and conditions, graphical prints, and graphical representations in relation to information regarding cardiovascular conditions and patient support programs
Class 035
providing information about medical records coding, billing, and compliance for patients with cardiac conditions for use by healthcare providers, patients, and caregivers
Class 036
Providing financial information about reimbursement for medical expenses for patients with cardiac conditions for use by healthcare providers, patients, and caregivers; providing insurance information about medical benefit verification and prior authorization services for patients with cardiac conditions for use by healthcare providers, patients, and caregivers
Class 041
Education services, namely, providing webinars, seminars, and conferences in the field of cardiac diseases; classes to caregivers and patients regarding treatments and support for cardiovascular conditions
Class 044
Providing information services in the field of cardiac disease for the purpose of patient support, namely, providing medical and healthcare information relating to pharmaceuticals and the treatment of heart diseases and conditions, and medical information about the administration and dosing of pharmaceuticals; Providing a website featuring healthcare information that provides resources in the field of pharmaceuticals for treatment of heart diseases and links to such resources; Providing a website featuring medical information, namely, a website featuring medical information related to patient support services, pharmaceuticals, pharmaceutical access, drug safety and drug compatibility in relation to treatment of individuals and adherence to pharmaceutical protocols; providing a website featuring medical information featuring information related to medical and diagnostic testing for heart diseases and conditions; medical care consulting services in the fields of patient treatment and treatment protocols; providing medical information and communication from a web site about cardiovascular diseases and conditions; patient healthcare education and services, namely, conducting one-on-one medical counseling in the fields of heart disease and conditions; Providing a website featuring educational information in the field of cardiovascular diseases and conditions about cardiac disease
Classification
International Classes
016
035
036
041
044